Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalworth Regulatory News (GWI)

Share Price Information for Globalworth (GWI)

Share Price is delayed by 15 minutes
Get Live Data
1.685    -0.005 (-0.30%)
Bid:
1.67
Ask:
1.70
Spread: 0.03 (1.796%)
Market Cap: €508.08m
GWI Live PriceLast checked at - London Stock Exchange

Intraday Globalworth Share Chart

Update on announcement from Consortium

26 Apr 2021 09:00

RNS Number : 5657W
Globalworth Real Estate Inv Ltd
26 April 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

26 April 2021

Globalworth Real Estate Investments Limited ("Globalworth" or the "Company")

Update on announcement from CPI Property Group S.A. and Aroundtown SA (the "Consortium")

On 14 April 2021, CPI Property Group S.A. and Aroundtown SA unilaterally announced a firm intention to make a cash offer for the share capital of Globalworth not already owned or controlled by them at EUR 7.00 per Globalworth share (the "Offer").

On 19 April 2021, Globalworth announced the formation of an independent committee of the Board (the "Independent Committee") to evaluate the Offer.

The Independent Committee values both members of the Consortium as shareholders and supporters of the Company. However, having considered the Offer with its advisers, it has concluded that the Offer significantly undervalues the Company, its assets and its prospects.

The Offer price of EUR 7.00 per Globalworth share represents a significant discount to the Company's EPRA NAV, which will be updated and published as part of the offer process, which was EUR 8.68 per share as of 31 December 2020.

The Offer also represents a discount of more than 27% to the Company's 6-month volume weighted average price as of 21 February 2020, being the last date prior to the start of the COVID-19 pandemic.

Accordingly, the Independent Committee advises Globalworth shareholders to take no action in relation to this Offer which materially undervalues the Company.

The Independent Committee notes that the Consortium has not sought a recommendation for the Offer.

The Independent Committee will provide Globalworth shareholders with its formal response to the Offer following publication of the offer document by the Consortium. Further announcements will be made as and when appropriate.

Enquiries:

 

Globalworth

Tel: +40 372 800 000

Geoff Miller, Chair of the Board

J.P. Morgan Cazenove (Financial Adviser)

Tel: +44 20 7742 4000

Massimo Saletti / Leon Li

Dwayne Lysaght / Jonty Edwards

 

 

Jefferies (Joint Broker)

Tel: +44 20 7029 8000

Stuart Klein

Panmure Gordon (Nominated Adviser and Joint Broker)

Tel: +44 20 7886 2500

Dominic Morley / Alina Vaskina / Joanna Langley

 

 

Important notices

This announcement is not intended to and does not constitute an offer to buy or the solicitation of an offer to subscribe for or sell or an invitation to purchase or subscribe for any securities or the solicitation of any vote in any jurisdiction. The release, publication or distribution of this announcement in whole or in part in, into or from certain jurisdictions may be restricted by law and therefore persons in such jurisdictions should inform themselves about and observe such restrictions.

The person responsible for arranging for the release of this announcement on behalf of the Company is Nicola Marrin, Company Secretary.

Disclaimer

J.P. Morgan Securities plc, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), is authorised in the United Kingdom by the Prudential Regulation Authority (the "PRA") and regulated in the United Kingdom by the PRA and the Financial Conduct Authority. J.P. Morgan Cazenove is acting as financial adviser exclusively for Globalworth and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than Globalworth for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, nor for providing advice in relation to any matter referred to herein.

Rule 26.1 Disclosure

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available at www.globalworth.com, by no later than 12 noon (London time) on the business day following the date of this announcement. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RSPPPUPCCUPGUMQ
Date   Source Headline
22nd Jun 202612:11 pmRNSResult of AGM
3rd Jun 20263:11 pmRNSFitch investment grade credit rating maintained
22nd May 202611:39 amRNSSatisfaction of employee share awards and TVR
15th May 20267:00 amRNSNotice of AGM and Availability of Annual Report
24th Apr 20265:35 pmRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSIssue of Scrip Dividend Shares & Admission to AIM
31st Mar 20267:00 amRNSAudited Results FY25, Annual Report, Notice of AGM
26th Mar 20261:00 pmRNSS&P - 'BB' Rating affirmed
19th Mar 20267:00 amRNSScrip Dividend Share Reference Price
27th Feb 20267:01 amRNSInterim Dividend & Scrip Alternative
27th Feb 20267:00 amRNSCondensed Unaudited Results for FY 31 Dec 2025
26th Jan 20261:00 pmRNSPartial Bond Redemption
6th Nov 202511:04 amRNSAppointment of Joint CEOs
23rd Sep 20257:00 amRNSHalf-year Report
28th Aug 20257:01 amRNSInterim Dividend Payment
28th Aug 20257:00 amRNSNotice of Interim Results & Prelim Interim Results
26th Jun 20251:41 pmRNSFitch investment grade credit rating maintained
23rd Jun 202512:42 pmRNSResult of AGM
23rd May 202511:45 amRNSBuy back of Shares into Treasury and TVR
15th May 20257:00 amRNSNotice of AGM
1st May 202511:30 amRNSSatisfaction of employee share awards and TVR
25th Apr 20255:35 pmRNSPulbication of Green Allocations Report
23rd Apr 202512:16 pmRNSExtension of secured bank financing
8th Apr 20253:18 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
27th Mar 20257:00 amRNSScrip Dividend Share Reference Price
25th Mar 20257:00 amRNSPublication of Annual Report and Date of AGM
21st Mar 20253:01 pmRNSS&P - revisions to credit rating and outlook
11th Mar 202511:13 amRNSInterim Dividend & Scrip Alternative
11th Mar 20257:00 amRNSCondensed Unaudited Results for FY 31 Dec 2024
18th Oct 20248:01 amRNSDirector/PDMR Shareholding
2nd Oct 20247:00 amRNSIssue of Scrip Dividend Shares & Admission to AIM
24th Sep 20247:00 amRNSHalf-year Report
19th Sep 20247:00 amRNSScrip Dividend Share Reference Price
16th Sep 20243:54 pmRNSHolding(s) in Company
30th Aug 20247:01 amRNSInterim Dividend & Scrip Alternative
30th Aug 20247:00 amRNSNotice of Interim Results & Prelim Interim Results
6th Aug 20244:10 pmRNSChange of Registered Office
18th Jul 20244:35 pmRNSResults of Tender Offers
11th Jul 20248:15 amRNSLaunch of Tender Offers for Bonds & Trading Updat
1st Jul 202412:01 pmRNSCredit Rating & Change of name of nomad
17th Jun 202410:18 amRNSResult of AGM
31st May 20243:03 pmRNSLogistics Sale Closing & Mandatory Bond Redemption
15th May 202410:14 amRNSNotice of AGM
7th May 202412:21 pmRNSBuyback of shares into treasury and TVR
26th Apr 20247:00 amRNSExchange Offer Final Settlement
22nd Apr 20244:35 pmRNSExchange Offer Final Results
11th Apr 20243:03 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
10th Apr 202411:49 amRNSExchange Offer Early Exchange Deadline Results
3rd Apr 20247:00 amRNSSatisfaction of employee share awards and TVR
28th Mar 20244:25 pmRNSExchange Offer for Outstanding Notes 2025 and 2026

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.